Healthand - Constant Contact

6 downloads 597 Views 5MB Size Report
Jan 28, 2017 - Call 888-M/HIR-55. Name. Spouse/Partner ... 1 Dr. Myers'presentation may be in person, or via video confe
Three easy ways to register! 1. Complete the form below and mail it to HIR, Inc. 2. Register online at www.MyHIR.org 3. Call 888-M/HIR-55 Name Spouse/Partner (if attending with you)

Street City State

.Zip.

HIR/ICARE Health Information Research, Inc. (HIR) is a 501 (c)3 nonprofit organization that organizes education symposiums for patients and medical practitioners who seek unbiased information and research related to the latest, most effective diagnostic and treatment methods for their disease. Founded in 2002 by David S. Most, PhD (1929-2016), HIR is continuing Dr. host's dedication to helping others by partnering with the International Cancer Alliance for Research and Education (ICARE) under the direction of ICARE Chairman W. David Hankins, PhD (www.icare.org).The collaboration of HIR and ICARE opens the door to new patient-focused opportunities including the ICARE global Investigative Teams (l-Teams), who identify cutting-edge therapeutic options and accelerate the clinical access to these advancements to patients and doctors. LEARN MORE ABOUT I-TEAMS,

Telephone _

SUNDAY, JANUARY 29™

Email D Check here if you'll be attending the Sunday morning ICARE Forum.

Early registration (before December 21,2016) $ 125.00 per person/$ 175.00 per couple After December 21,2016 $ 145 per person/$ 195 per couple Includes refreshments and lunch Limited Scholarships Available Please make checks payable to HIR, Inc. and mail to: Health Information Research, Inc. 5265 University Parkway Suite 101, Box 327 University Park, FL 34201

On Sunday morning,January 29th, an ICARE Forum will be held to introduce the I-TEAMS concept, which matches patients with the world's leading physicians and cancer researchers. Participants will learn how I-TEAMS increase the flow of new, life-saving information, hasten drug development, and serve as advocates for creativity and innovative thinking in cancer research. Attendance at the ICARE Forum is included in the Symposium fee. All Symposium attendees are invited to register for the Prostate I-TEAM being launched and/or emerging I-TEAMS for other cancers and life-threatening disorders. For further information about HIR, HIR symposiums, ICARE and l-Teams, email or call:

[email protected] Symposium location Florida Atlantic University Student Union 777 Glades Road Boca Raton, FL

888-MyHIR-55

fcare Curing Cancer One Patient did H..H

The W. B. Ingalls Memorial Prostate Health and Cancer Symposium is held in honor of former South Florida resident, Mr. Brad Ingalls, who passed away in 2005 after a 10-year battle with prostate cancer. The Ingalls Charitable Foundation was established in his memory to support medical research and programs to increase awareness of and education in this disease.

W.B. Ingalls

Health and

Cancer Symposium

1

Saturday, January 28, 2017 Florida Atlantic University Boca Raton, Florida 'ull-day event featuring leading prostate conce physicians and researchers sharing the latest advancements and results in diagnostic and treatment protocols Sponsors: W. Bradford Ingalls Foundation ICARE International Prostate Investigative Team (I-Team) Scripps Research Institute

SCIENTIFIC PRESENTATIONS Review of immunotherapy strategies and clinical trials for prostate cancer Ravi A. Madan, MD Clinical Director of the Genitourinary Malignancies Branch Center for Cancer Research National Cancer Institute, NIH Bethesda, MD

PSA rising? New protocols: MRI-guided biopsy for detection and a "focal" therapy eliminates harmful side-effects of surgery Mark Emberton, MD Dean, UCL Faculty of Medical Sciences Professor, Interventional Oncology University College London London, UK

Treating advanced prostate cancer: The importance of a complete durable remission and ways to achieve it Charles "Snuffy" Myers, MD* Founder and Medical Director American Institute for Diseases of the Prostate (AIDP) Co-Founder and President Foundation for Cancer Research and Education Earlysville.VA

Paradigm shifts in prostate cancer therapy Christopher J. Logothetis, MD Chairman and Professor, Department of Genitourinary Medical Oncology MD Anderson Cancer Center Houston.TX

1

Dr. Myers'presentation may be in person, or via video conference.

Active surveillance of early prostate cancer: Why, when and how to start and change therapeutic course Jonathan I. Epstein, MD, PhD The Reinhard Professor of Urologic Pathology John Hopkins Medicine Baltimore, MD

ICARE PROGRAM Symposium Organizer W. David Hankins, PhD Chairman, ICARE (International Cancer Alliance for Research and Education) Executive Director, Health Information Research, Inc.

Being an empowered patient in the complex healthcare system Review of the most valuable genetic and laboratory assays to determine successful prostate treatment strategies David Bostwick, MD, MBA Founder and CEO Bostwick (Anatomic Pathology) Laboratories, Inc. Richmond,VA

Lethal weapons against prostate cancer: Novel therapeutic approaches to target the two genes synergistically driving aggressive prostate cancer Andrea Califano, PhD Professor, Chemical and Systems Biology mtf i Department of Biomedical Informatics Columbia University New York, NY

Anne Llewellyn, RN-BC, MS, BHSA, CCM, CRRN Nurse Advocate Fort Lauderdale, FL

Margaret "Peggy' Leonard, MS, RN-BC, FNP Vice President of Government and Community Initiatives MVP Health Care Schenectady, NY

The Actual Dance Samuel A. Simon Playwright, performer and artistic director Presenting at Sunday morning ICARE Forum

Presenters' Panel moderated by: George Hemstreet, MD, PhD Chief of Urology, Omaha Veterans Administration Hospital Site Director for the Urology Residency Programs at Creighton University Medical Center and the University of Nebraska Medical Center Omaha, NE

Cocktail Reception Networking Exhibition Hall until 7:00 pm

For information or registration visit www.MyHIR.org or call 888-MyHIR-55